INULIN Drug Patent Profile
✉ Email this page to a colleague
When do Inulin patents expire, and what generic alternatives are available?
Inulin is a drug marketed by Iso Tex and is included in one NDA.
The generic ingredient in INULIN is inulin. There is one drug master file entry for this compound. Additional details are available on the inulin profile page.
Summary for INULIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INULIN at DailyMed |
Recent Clinical Trials for INULIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2 |
Centre Hospitalier Universitaire de Saint Etienne | Phase 1 |
Yanqing Li | Early Phase 1 |
US Patents and Regulatory Information for INULIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iso Tex | INULIN AND SODIUM CHLORIDE | inulin | INJECTABLE;INJECTION | 002282-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |